In our portfolio of dozens of startups and businesses, Tekedia Capital chooses Revna BioSciences as the best portfolio company in February 2025. Revna Biosciences is a first Ghana -based precision medicine research company, known for its advanced molecular diagnostic services and clinical research.
The company is a clarification of precision medicine innovation in West Africa, offering advanced molecular diagnostics and leading to a significant paradigm change in advanced molecular diagnostics through the African continent. He is an active member of the American Association for Laboratory Accreditation (A2LA).
Revnabio will also launch operations in Nigeria later this year. His services save lives. Tekedia Capital directed the first and second cycles of financing of this company and remains proud of our efforts to finance catalytic projects in Africa.
Register For TEKEDIA Mini-MBA Edition 16 (February 10 – May 3, 2025)) Today for early reductions.
Tekedia Ai in Masterclass Business open registration.
Join Tekedia Capital Syndicate and co-INivest in large world startups.
Register become a better CEO or director with CEO program and director of Tekedia.
—
Register at Tekedia Mini-MBA (February 10 to May 3, 2025) and join Professor Ndubuisi Ekekwe and our world faculty; Click here.
